Evidence map›Paper›PMID 26277341›Full record

ArticleNeuropharmacology2015

Upregulation of orexin receptor in paraventricular nucleus promotes sympathetic outflow in obese Zucker rats.

Jing-Jing Zhou, Fang Yuan, Yi Zhang, De-Pei Li

Abstract read
In one paragraph

Article in Neuropharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Midlife estradiol treatment reduces the firing rate of liver-related PVN neurons in ovariectomized high-fat diet-fed mice.American journal of physiology. Regulatory, integrative and comparative physiology · 2025
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. The Orexin System and Hypertension.Cellular and molecular neurobiology · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Jing-Jing ZhouDepartment of Physiology, Hebei Medical University, Shijiazhuang, Hebei 050017, China; Department of Critical Care, The University of Texas, M.D. Anderson Cancer Center, Houston, TX 77030, USA.
Fang YuanDepartment of Physiology, Hebei Medical University, Shijiazhuang, Hebei 050017, China.
Yi ZhangDepartment of Physiology, Hebei Medical University, Shijiazhuang, Hebei 050017, China; Hebei Collaborative Innovation Center for Cardio-cerebrovascular Disease, Shijiazhuang, Hebei 050000, China. Electronic address: zhyhenry@hotmail.com.
De-Pei LiDepartment of Critical Care, The University of Texas, M.D. Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: dpli@mdanderson.org.
Hebei Medical University · CNThe University of Texas MD Anderson Cancer Center · US

Funding

Hypothalamic Neuronal Plasticity in Chronic StressR01MH096086 · NIMH · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI LI, DE-PEI · 2013 to 2017
$1.8M
NIMH NIH HHS MH096086NIMH NIH HHS R01 MH096086
6 · The paper itself

Abstract

Sympathetic vasomotor tone is elevated in obesity-related hypertension. Orexin importantly regulates energy metabolism and autonomic function. We hypothesized that alteration of orexin receptor in the paraventricular nucleus (PVN) of the hypothalamus leads to elevated sympathetic vasomotor tone in obesity. We used in vivo measurement of sympathetic vasomotor tone and microinjection into brain nucleus, whole-cell patch clamp recording in brain slices, and immunocytochemical staining in obese Zucker rats (OZRs) and lean Zucker rats (LZRs). Microinjection of orexin 1 receptor (OX1R) antagonist SB334867 into the PVN reduced basal arterial blood pressure (ABP) and renal sympathetic nerve activity (RSNA) in anesthetized OZRs but not in LZRs. Microinjection of orexin A into the PVN produced greater increases in ABP and RSNA in OZRs than in LZRs. Western blot analysis revealed that OX1R expression levels in the PVN were significantly increased in OZRs compared with LZRs. OX1R immunoreactivity was positive in retrogradely labeled PVN-spinal neurons. The basal firing rate of labeled PVN-spinal neurons was higher in OZRs than in LZRs. SB334867 decreased the basal firing activity of PVN-spinal neurons in OZRs but had no effect in LZRs. Orexin A induced a greater increase in the firing rate of PVN-spinal neurons in OZRs than in LZRs. In addition, orexin A induced larger currents in PVN-spinal neurons in OZRs than in LZRs. These data suggest that upregulation of OX1R in the PVN promotes hyperactivity of PVN presympathetic neurons and elevated sympathetic outflow in obesity.

Indexed as

Action PotentialsAnimalsBenzoxazolesBlood PressureCentral Nervous System AgentsDisease Models, AnimalMaleNaphthyridinesNeuroanatomical Tract-Tracing TechniquesNeuronsObesityOrexin ReceptorsOrexinsParaventricular Hypothalamic NucleusRats, ZuckerSpinal Cord1-(2-methylbenzoxazol-6-yl)-3-(1,5)naphthyridin-4-yl ureaBenzoxazolesCentral Nervous System AgentsNaphthyridinesOrexin ReceptorsOrexinsUreaHypothalamusObesityOrexin receptorsSympathetic nerve activity

Identifiers

PMID26277341
PMCPMC4841448
OpenAlexW1164255036

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.